NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22% in Q4 and expects sequential increase in revenues for Q1 2022 -Management to host conference call on Monday, May 2, 2022 at 11:00 AM ET -...
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
CARLSBAD, Calif, April 29, 2022 -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22% in Q4 and expects sequential increase in revenues for Q1 2022 -Management to host conference call on Monday,...
Aurora Spine Corporation Schedules Release for Fourth Quarter and Fiscal Year 2021 Financial Results and Conference Call
CARLSBAD, Calif., April 28, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial...
Aurora Spine: Simplifying the Complex KOL Panel
Thank you for joining us here today for a panel discussion hosted by Aurora Spine titled Simplifying the Complex, a panel discussion with doctors that use Aurora Spine products. We are joined by great doctors from different industry backgrounds to get some insights on...
Aurora Spine Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference
CARLSBAD, Calif., March 31, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, announced today that it will be participating in the Lytham Partners Spring 2022 Investor...
Aurora Spine Corporation Announces Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
Dr. Sebastian Koga, Neurosurgeon completes the first surgeries using Aurora Spine's DEXA-C patient matched implantCARLSBAD, Calif., March 03, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative...
Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical
Aurora Spine's DEXA Technology patient-matched implants supported by Echolight's newest technologies in bone health assessmentCARLSBAD, Calif., Feb. 24, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of...
Aurora Spine Corporation Announces Preliminary Revenue for Fourth Quarter and Fiscal 2021
- Company experiencing improved sales momentum from proprietary products -CARLSBAD, Calif., Feb. 22, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve...
Aurora Spine Receives “Notice of Allowance” for Patent for Spinal Implant for Motion Preservation or Fusion
- New Patent will Strengthen Company's IP Portfolio - CARLSBAD, Calif., Feb. 07, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery...
Aurora Spine Announces Initial Surgeries Using its Proprietary APOLLOTM Cervical Plate
CARLSBAD, Calif., Jan. 25, 2022 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that the first anterior cervical...